The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Cancer and systemic inflammation: treat the tumour and treat the host
Open accessAbstract
Determinants of cancer progression and survival are multifactorial and host responses are increasingly appreciated to have a major role. Indeed, the development and maintenance of a systemic inflammatory response has been consistently observed to confer poorer outcome, in both early and advanced stage disease. For patients, cancer-associated symptoms are of particular importance resulting in a marked impact on day-to-day quality of life and are also associated with poorer outcome. These symptoms are now recognised to cluster with one another with anorexia, weight loss and physical function forming a recognised cluster whereas fatigue, pain and depression forming another. Importantly, it has become apparent that these symptom clusters are associated with presence of a systemic inflammatory response in the patient with cancer. Given the understanding of the above, there is now a need to intervene to moderate systemic inflammatory responses, where present. In this context the rationale for therapeutic intervention using nonselective anti-inflammatory agents is clear and compelling and likely to become a part of routine clinical practice in the near future. The published literature on therapeutic intervention using anti-inflammatory agents for cancer-associated symptoms was reviewed. There are important parallels with the development of useful treatments for the systemic inflammatory response in patients with rheumatological disease and cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
Self-citationMcMillan, D. C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.003 · Cited by 1,398
Self-citationRoxburgh, C. S., & McMillan, D. C. (2010) · Future Oncology · doi:10.2217/fon.09.136 · Cited by 998
Self-citationAnti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 915
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 843
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Dantzer, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.040 · Cited by 743
McMillan, D. C. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108007131 · Cited by 472
Self-citationYennurajalingam, S., Frisbee-Hume, S., Palmer, J. L., Delgado-Guay, M. O., Bull, J., Phan, A. T., Tannir, N. M., Litton, J. K., Reddy, A., Hui, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.4661 · Cited by 348
Lundholm, K., Gélin, J., Hyltander, A. G., Lönnroth, C., Sandström, R., Svaninger, G., Körner, U., Gulich, M. P., Kärrefors, I., & Norli, B. (1994) · PubMed · Cited by 309
Laird, B. J., Kaasa, S., McMillan, D. C., Fallon, M. T., Hjermstad, M. J., Fayers, P., & Klepstad, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1066 · Cited by 211
Self-citationProctor, M. J., Talwar, D., Balmar, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., Morrison, D. S., & McMillan, D. C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605855 · Cited by 204
Self-citationIlli, J., Miaskowski, C., Cooper, B., Levine, J. D., Dunn, L., West, C., Dodd, M., Dhruva, A., Paul, S. M., Baggott, C., et al. (2012) · Cytokine · doi:10.1016/j.cyto.2012.02.015 · Cited by 185
McMillan, D. C., Wigmore, S. J., Wigmore, K. C. H., O’Gorman, P., Wright, C. E., & McArdle, C. S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690077 · Cited by 174
Self-citationPain, Depression, and Fatigue as a Symptom Cluster in Advanced Cancer
Laird, B. J. A., Scott, A. C., Colvin, L. A., McKeon, A.-L., Murray, G. D., Fearon, K. C. H., & Fallon, M. T. (2011) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.10.261 · Cited by 170
Douglas, E., & McMillan, D. C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.007 · Cited by 170
Self-citationA systematic review of the association between immunogenomic markers and cancer-related fatigue
Saligan, L. N., & Kim, H. S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.05.004 · Cited by 167
Laird, B. J. A., McMillan, D. C., Fayers, P. M., Fearon, K., Kaasa, S., Fallon, M., & Klepstad, P. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0120 · Cited by 166
Self-citationMadeddu, C., Dessì, M., Panzone, F., Serpe, R., Antoni, G., Cau, M. C., Montaldo, L., Mela, Q., Mura, M., Astara, G., et al. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.10.005 · Cited by 153
Trajkovic, M., de Graeff, A., Voest, E. E., & Teunissen, S. C. C. M. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.02.011 · Cited by 126
Macdonald, N. (2007) · PubMed · Cited by 113
Non-steroidal anti-inflammatory treatment in cancer cachexia: A systematic literature review
Solheim, T. S., Fearon, K. C. H., Blum, D., & Kaasa, S. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.724536 · Cited by 112
Kacevska, M., Robertson, G. R., Clarke, S. J., & Liddle, C. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.137 · Cited by 104
Cancer Symptom Clusters: Old Concept But New Data
Kirkova, J., Walsh, D., Aktaş, A., & Davis, M. P. (2010) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909110364048 · Cited by 98
Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803
Ng, K., Ogino, S., Meyerhardt, J. A., Chan, J. A., Chan, A. T., Niedzwiecki, D., Hollis, D. R., Saltz, L. B., Mayer, R. J., Benson, A. B., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr307 · Cited by 96
Solheim, T. S., Blum, D., Fayers, P. M., Hjermstad, M. J., Stene, G. B., Strasser, F., & Kaasa, S. (2013) · Acta Oncologica · doi:10.3109/0284186x.2013.823239 · Cited by 85
Cancer and systemic inflammation: stage the tumour and stage the host
McMillan, D. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.418 · Cited by 45
Self-citationCancer, cachexia, prostanoids, and NSAIDs
Christoffersen, T. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.750429 · Cited by 6
Cited by
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Self-citationESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305
Self-citationPharmacokinetics of Monoclonal Antibodies
Ryman, J. T., & Meibohm, B. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12224 · Cited by 802
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Tanaka, K., Fushiya, N., Koike, K., Nishino, H., & Matsushima, M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4048-0 · Cited by 442
Influence of body composition profile on outcomes following colorectal cancer surgery
Malietzis, G., Currie, A. C., Athanasiou, T., Johns, N., Anyamene, N., Glynne-Jones, R., Kennedy, R. H., Fearon, K. C. H., & Jenkins, J. T. (2016) · British Journal of Surgery · doi:10.1002/bjs.10075 · Cited by 299
Metadata
- Authors
- Roxburgh, C. S. D., & McMillan, D. C.
- Venue
- British Journal of Cancer
- Published
- 2014-02-18
- Volume
- 110
- Issue
- 6
- Pages
- 1409-1412
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2131193892
- Cited by
- 368
- References
- 32
- FWCI
- 11.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.